3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats

Effects of the α7 Nicotinic Acetylcholine Receptor Agonist Gts-21 on the Innate Immune Response in Humans

(2011) Matthijs Kox et al.   SHOCK

Missing pieces in the Parkinson's disease puzzle

(2010) Jose A Obeso et al.   NATURE MEDICINE

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease

(2009) Bruno P Imbimbo   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection

(2009) Akinori Akaike et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Unknown

(2009) Mauricio Rosas-Ballina et al.   MOLECULAR MEDICINE

Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function

(2009) Edson X. Albuquerque et al.   PHYSIOLOGICAL REVIEWS

Animal models of Parkinson’s disease progression

(2008) Gloria E. Meredith et al.   ACTA NEUROPATHOLOGICA

Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

(2008) Robert Freedman et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease

(2008)   CLINICAL NEUROPHARMACOLOGY

In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for Parkinson's Disease

(2008) J. Andrés Abin-Carriquiry et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models

(2008) Hiroki Takeuchi et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model

(2008) Takashi Yanagida et al.   NEUROSCIENCE RESEARCH

Glial reactions in Parkinson's disease

(2007) Patrick L. McGeer et al.   MOVEMENT DISORDERS